The company discontinued developing emugrobart after two studies showed the drug didn’t achieve intended outcomes.
Kelly Chibale says that the hunt for new drugs is kind of like a fairy-tale quest. And it takes a lot of time and patience.
An experimental treatment for eczema from Apogee Therapeutics induced skin and itch relief comparable to current, widely used ...
HHS has made reducing animal testing a priority over the past year. In April 2025, the FDA announced it would phase out the ...
Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...
Patients with obesity sometimes have leptin resistance, and the "full" feeling does not get through to the brain. The new ...
MedPage Today on MSN
FDA Proposes More Flexibility in Alternatives to Animal Testing in Drug Development
Non-animal testing methods could save drugmakers time and money, officials say ...
In a recently published review, a research team led by MedUni Vienna has highlighted a promising new approach to drug discovery. The focus is on the targeted modulation of certain intracellular ...
The GLP-1 PR has been a little too good. Everyone knows the drugs lead to rapid weight loss — including participants in ...
It’s always a high-stakes gamble in the pharmaceutical industry to develop a new drug. The process typically takes 10 to 15 years and requires extensive testing, regulatory approval, and clinical ...
There has been much discussion recently about how artificial intelligence and machine learning (AI/ML) will revolutionize pharmaceutical research. Substantial progress has been made in the discovery ...
To study this transformation, we compile a comprehensive, synchronized database spanning the pharmaceutical drug development supply chain, covering scientific publications, clinical trials, drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results